Cocrystal Pharma (COCP) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.02, -0.97% vs the prior close of $1.03.
- Volume 22.77K shares, 0.4x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
COCP dips 1.0% to $1.02, a 1-month low, 3 down days in a row. Closed at $1.02, -0.97% vs the prior close of $1.03. Day range $1.01–$1.06, opened at $1.04.
COCP daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — COCP dips 1.0% to $1.02, a 1-month low, 3 down days in a row
- Closed at $1.02, -0.97% vs the prior close of $1.03. Day range $1.01–$1.06, opened at $1.04.
- Volume was 22.77K shares, 0.4x its 50-day average of 54.06K — lighter than usual.
- Price is -9.7% vs its 50-day average ($1.13) and -7.9% vs its 200-day average ($1.11).
- 52-week range $0.76–$2.03; today's close sits at 20% of that range, 49.8% below the 52-week high.
- That makes 3 straight losses.
Oct 15, 2026 — COCP dips 1.0% to $1.03, a 1-month low
- Closed at $1.03, -0.96% vs the prior close of $1.04. Day range $1.01–$1.06, opened at $1.02.
- Volume was 45.50K shares, 0.8x its 50-day average of 54.53K.
- Price is -8.9% vs its 50-day average ($1.13) and -7.0% vs its 200-day average ($1.11).
- 52-week range $0.76–$2.03; today's close sits at 21% of that range, 49.3% below the 52-week high.
Oct 14, 2026 — COCP slides 3.7% to $1.04, a 1-month low
- Closed at $1.04, -3.70% vs the prior close of $1.08. Day range $1.04–$1.08, opened at $1.05.
- Volume was 46.00K shares, 0.8x its 50-day average of 55.93K.
- Price is -8.0% vs its 50-day average ($1.13) and -6.1% vs its 200-day average ($1.11).
- 52-week range $0.76–$2.03; today's close sits at 22% of that range, 48.8% below the 52-week high.
Oct 13, 2026 — COCP rises 1.9% to $1.08
- Closed at $1.08, +1.89% vs the prior close of $1.06. Day range $1.02–$1.11, opened at $1.05.
- Volume was 86.70K shares, 1.4x its 50-day average of 62.55K.
- Price is -4.3% vs its 50-day average ($1.13) and -2.4% vs its 200-day average ($1.11).
- 52-week range $0.76–$2.03; today's close sits at 25% of that range, 46.8% below the 52-week high.
Oct 12, 2026 — COCP dips 0.9% to $1.06
- Closed at $1.06, -0.93% vs the prior close of $1.07. Day range $1.05–$1.08, opened at $1.07.
- Volume was 9.00K shares, 0.1x its 50-day average of 63.06K — lighter than usual.
- Price is -5.9% vs its 50-day average ($1.13) and -4.2% vs its 200-day average ($1.11).
- 52-week range $0.76–$2.03; today's close sits at 24% of that range, 47.8% below the 52-week high.
Oct 9, 2026 — COCP ends flat (+0.0%) to $1.07
- Closed at $1.07, +0.00% vs the prior close of $1.07. Day range $1.06–$1.08, opened at $1.06.
- Volume was 4.00K shares, 0.1x its 50-day average of 63.45K — lighter than usual.
- Price is -4.6% vs its 50-day average ($1.12) and -3.3% vs its 200-day average ($1.11).
- 52-week range $0.76–$2.03; today's close sits at 24% of that range, 47.3% below the 52-week high.
Oct 8, 2026 — COCP rises 0.9% to $1.07
- Closed at $1.07, +0.94% vs the prior close of $1.06. Day range $1.06–$1.10, opened at $1.06.
- Volume was 29.00K shares, 0.5x its 50-day average of 64.35K — lighter than usual.
- Price is -4.2% vs its 50-day average ($1.12) and -3.2% vs its 200-day average ($1.11).
- 52-week range $0.76–$2.03; today's close sits at 24% of that range, 47.3% below the 52-week high.
Oct 7, 2026 — COCP slides 4.5% to $1.06, a 1-month low, 3 down days in a row
- Closed at $1.06, -4.50% vs the prior close of $1.11. Day range $1.06–$1.11, opened at $1.11.
- Volume was 30.20K shares, 0.5x its 50-day average of 64.08K — lighter than usual.
- Price is -4.8% vs its 50-day average ($1.11) and -4.1% vs its 200-day average ($1.11).
- 52-week range $0.76–$2.03; today's close sits at 24% of that range, 47.8% below the 52-week high.
- That makes 3 straight losses.
Oct 6, 2026 — COCP ends flat (+0.0%) to $1.11
- Closed at $1.11, +0.00% vs the prior close of $1.11. Day range $1.10–$1.13, opened at $1.11.
- Volume was 28.50K shares, 0.4x its 50-day average of 64.01K — lighter than usual.
- Price is -0.1% vs its 50-day average ($1.11) and +0.5% vs its 200-day average ($1.10).
- 52-week range $0.76–$2.03; today's close sits at 28% of that range, 45.3% below the 52-week high.
Oct 5, 2026 — COCP slides 3.5% to $1.11, a 1-month low
- Closed at $1.11, -3.48% vs the prior close of $1.15. Day range $1.11–$1.18, opened at $1.18.
- Volume was 41.20K shares, 0.6x its 50-day average of 63.95K.
- Price is +0.3% vs its 50-day average ($1.11) and +0.5% vs its 200-day average ($1.10).
- 52-week range $0.76–$2.03; today's close sits at 28% of that range, 45.3% below the 52-week high.
Oct 2, 2026 — COCP rises 0.9% to $1.15
- Closed at $1.15, +0.88% vs the prior close of $1.14. Day range $1.14–$1.17, opened at $1.17.
- Volume was 13.70K shares, 0.2x its 50-day average of 64.47K — lighter than usual.
- Price is +4.3% vs its 50-day average ($1.10) and +4.2% vs its 200-day average ($1.10).
- 52-week range $0.76–$2.03; today's close sits at 31% of that range, 43.3% below the 52-week high.
COCP latest news & SEC filings
Every SEC filing by or about COCP in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 9, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 21, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Aug 18, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Aug 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $105.00K
- Net income: -$3.16M (prior year -$2.06M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.23 (prior year -$0.20) (loss widened vs Jun 30, 2025)
Aug 7, 2026 · Form SCHEDULE 13D — Activist-style stake (13D)
Activist-style stake (13D) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 7, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Frost Phillip Md Et Al bought 10,000 shares at $0.98 (≈$9.80K) on Aug 5, 2026
- Frost Phillip Md Et Al bought 10,000 shares at $0.98 (≈$9.80K) on Aug 5, 2026
- Frost Phillip Md Et Al bought 10,000 shares at $0.98 (≈$9.80K) on Aug 5, 2026
- Frost Phillip Md Et Al bought 10,000 shares at $0.98 (≈$9.80K) on Aug 5, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Frost Phillip Md Et Al bought 75,000 shares at $0.94 (≈$70.50K) on Aug 3, 2026
- Frost Phillip Md Et Al bought 75,000 shares at $0.94 (≈$70.50K) on Aug 3, 2026
- Frost Phillip Md Et Al bought 75,000 shares at $0.94 (≈$70.50K) on Aug 3, 2026
- Frost Phillip Md Et Al bought 75,000 shares at $0.94 (≈$70.50K) on Aug 3, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 3, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jul 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Things to know before you trade COCP
- Last results release: Mar 31, 2026 (8-K Item 2.02). Previous ones: Nov 14, 2025, Aug 14, 2025, May 15, 2025. Based on that rhythm, the next report is likely around Jun 30, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.97% (largest 7.4%).
- Liquidity: about 39.39K shares (≈$40.18K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.02 vs a range of $0.76–$2.03 (20% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Phillip Md Et Al Frost bought 10,000 shares on Aug 5, 2026.
- Latest filings: 8-K Sep 9, 2026; 8-K Aug 18, 2026; 8-K Aug 17, 2026.
- Share count: 19.26M shares outstanding (Aug 13, 2026), +87.8% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
COCP market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.04 | 1.06 | 1.01 | 1.02 | 22.77K |
| Oct 15, 2026 | 1.02 | 1.06 | 1.01 | 1.03 | 45.50K |
| Oct 14, 2026 | 1.05 | 1.08 | 1.04 | 1.04 | 46.00K |
| Oct 13, 2026 | 1.05 | 1.11 | 1.02 | 1.08 | 86.70K |
| Oct 12, 2026 | 1.07 | 1.08 | 1.05 | 1.06 | 9.00K |
| Oct 9, 2026 | 1.06 | 1.08 | 1.06 | 1.07 | 4.00K |
| Oct 8, 2026 | 1.06 | 1.10 | 1.06 | 1.07 | 29.00K |
| Oct 7, 2026 | 1.11 | 1.11 | 1.06 | 1.06 | 30.20K |
| Oct 6, 2026 | 1.11 | 1.13 | 1.10 | 1.11 | 28.50K |
| Oct 5, 2026 | 1.18 | 1.18 | 1.11 | 1.11 | 41.20K |
| Oct 2, 2026 | 1.17 | 1.17 | 1.14 | 1.15 | 13.70K |
| Oct 1, 2026 | 1.18 | 1.18 | 1.12 | 1.14 | 68.00K |
| Sep 30, 2026 | 1.14 | 1.19 | 1.12 | 1.15 | 12.70K |
| Sep 29, 2026 | 1.24 | 1.24 | 1.10 | 1.12 | 121.00K |
| Sep 28, 2026 | 1.19 | 1.22 | 1.15 | 1.21 | 32.10K |
| Sep 25, 2026 | 1.18 | 1.18 | 1.14 | 1.17 | 13.40K |
| Sep 24, 2026 | 1.21 | 1.21 | 1.13 | 1.15 | 47.90K |
| Sep 23, 2026 | 1.17 | 1.28 | 1.16 | 1.19 | 26.10K |
| Sep 22, 2026 | 1.21 | 1.28 | 1.19 | 1.19 | 69.00K |
| Sep 21, 2026 | 1.20 | 1.25 | 1.19 | 1.19 | 41.10K |
About Cocrystal Pharma
Cocrystal Pharma (COCP) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in BOTHELL, WA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1412486.
COCP board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Carol L Brosgart | Director | Aug 21, 2026 |
| Phillip Md Et Al Frost | Director | Aug 6, 2026 |
| Fred Hassan | Director | Jan 13, 2026 |
| Anthony J Japour | Director | Jan 13, 2026 |
| Roger D. Kornberg | Director | Jan 13, 2026 |
| Richard C Jr Pfenniger | Director | Jan 13, 2026 |
| Steven D Rubin | Director | Jan 13, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Sam Lee | President and Co-CEO | Jan 13, 2026 |
| James Joseph Martin | Co-CEO and CFO | Jan 13, 2026 |
| James Sapirstein | Chief Executive Officer | Jun 3, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 5, 2026 | Phillip Md Et Al Frost | Buy | 10,000 | $0.98 |
| Aug 5, 2026 | Phillip Md Et Al Frost | Buy | 10,000 | $0.98 |
| Aug 5, 2026 | Phillip Md Et Al Frost | Buy | 10,000 | $0.98 |
| Aug 5, 2026 | Phillip Md Et Al Frost | Buy | 10,000 | $0.98 |
| Aug 3, 2026 | Phillip Md Et Al Frost | Buy | 75,000 | $0.94 |
| Aug 3, 2026 | Phillip Md Et Al Frost | Buy | 75,000 | $0.94 |
| Aug 3, 2026 | Phillip Md Et Al Frost | Buy | 75,000 | $0.94 |
| Aug 3, 2026 | Phillip Md Et Al Frost | Buy | 75,000 | $0.94 |
| Feb 24, 2026 | Phillip Md Et Al Frost | Buy | 20,000 | $1.00 |
| Feb 24, 2026 | Phillip Md Et Al Frost | Buy | 20,000 | $1.00 |
| Feb 24, 2026 | Phillip Md Et Al Frost | Buy | 20,000 | $1.00 |
| Feb 24, 2026 | Phillip Md Et Al Frost | Buy | 20,000 | $1.00 |
| Feb 6, 2026 | Phillip Md Et Al Frost | Buy | 50,000 | $0.95 |
| Feb 6, 2026 | Phillip Md Et Al Frost | Buy | 50,000 | $0.95 |
| Feb 6, 2026 | Phillip Md Et Al Frost | Buy | 50,000 | $0.95 |
COCP financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-8.83M | -0.78 | $-8.19M |
| Dec 31, 2024 | — | $-17.50M | -1.72 | $-16.48M |
| Dec 31, 2023 | — | $-17.98M | -1.87 | $-14.67M |
| Dec 31, 2022 | — | $-38.84M | -4.77 | $-21.43M |
| Dec 31, 2021 | — | $-14.19M | — | $-12.72M |
Latest balance sheet: total assets $4.65M, total liabilities $3.60M, cash $7.03M (as of Jun 30, 2026).
COCP earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Mar 31, 2026 | 8-K Item 2.02 (results) | $1.01 |
| Nov 14, 2025 | 8-K Item 2.02 (results) | $1.03 |
| Aug 14, 2025 | 8-K Item 2.02 (results) | $1.68 |
| May 15, 2025 | 8-K Item 2.02 (results) | $1.44 |
| Mar 31, 2025 | 8-K Item 2.02 (results) | $1.42 |
| Nov 13, 2024 | 8-K Item 2.02 (results) | $1.77 |
| Aug 14, 2024 | 8-K Item 2.02 (results) | — |
| May 13, 2024 | 8-K Item 2.02 (results) | — |
| Mar 28, 2024 | 8-K Item 2.02 (results) | — |
| Nov 13, 2023 | 8-K Item 2.02 (results) | — |
| Aug 16, 2023 | 8-K Item 2.02 (results) | — |
| May 15, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on COCP
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.